Neurovascular Devices Market Size 2023-2030: Medtronic, Johnson & Johnson, Stryker, ASAHI INTECC CO., LTD., Terumo Corporation

Delvens published an exclusive report, titled, "Neurovascular Devices Market Size 2023-2030: Medtronic, Johnson & Johnson, Stryker, ASAHI INTECC CO., LTD., Terumo Corporation". Neurovascular Devices Market Size, Share & Trends Analysis Report, By Device (Cerebral Embolization & Aneurysm Coiling Devices), By Therapeutic Application (Stroke, Cerebral Artery Stenosis), and region (North America, Europe, Asia-Pacific, Middle East, and Africa and South America).

Get a FREE Sample Copy of this Report with Graphs and Charts at: https://www.delvens.com/get-free-sample/neurovascular-devices-market-trends-forecast-till-2030

Neurovascular Devices Market Competitive Landscape: Medtronic, Johnson and Johnson Services Inc., Penumbra, Inc., Microport Scientific Corporation, Stryker, Microvention Inc (Terumo Corporation), Codman Neuro (Integra Lifesciences)

Johnson & Johnson has announced the release of Cerenovus Stroke Solutions, a trio of devices that will aid medical professionals in clot removal procedures, in 2020.

The Surpass Evolve Flow Diverter was introduced by Stryker Corporation in the United States in August 2020 following FDA approval.

Regional Analysis

Asia Pacific to Dominate the Market

Due to the presence of major producers in the North American region, including Stryker Corporation, Penumbra, Inc., Johnson & Johnson, and Merit Medical Systems, Inc., North America held the largest market share and dominated the market in 2021.

Due to factors including the increasing prevalence of target diseases, Asia Pacific is anticipated to expand at the greatest CAGR during the projection period.

Vascular disorders of the brain and central nervous system are diagnosed and treated with the aid of interventional neurology devices. Angiography, fluoroscopy, endovascular procedures, and catheter-based techniques are all included in interventional neurology. One of the earliest primary in-vivo brain vascular imaging techniques, catheter angiography is used to diagnose a number of neurological diseases, including cerebral aneurysm, arteriovenous malformations, intracranial stenosis, arteriovenous fistula, and vasculitis.

The market is anticipated to be driven by the rising frequency of neurological illnesses, technological developments, and rising demand for less invasive procedures. The increase in R&D investments in the biotechnology and pharmaceutical industry will also be the major driving factor of the neurovascular devices market. An expanding patient population for ischemic and hemorrhagic stroke as well as a rise in demand for minimally invasive treatments for neurovascular disease may be to blame for the market's expansion.

The market is anticipated to be moderately and temporarily affected by COVID-19. Depending on the state of the local health systems and the steps taken to battle the pandemic, the effect of the epidemic on the market differs by country. The epidemic has had a negative effect on neuro care and neurosurgeons. Brain procedures have frequently been delayed or even canceled during this time in order to stop the coronavirus from spreading.

Neurosurgical operations decreased by 55% in the worst-affected countries, including the United States, Russia, India, Brazil, France, the United Kingdom, Italy, and Spain. However, up to 36% of hospitalized COVID-19 patients may experience neurological symptoms, and there have been several cases of ischemic and hemorrhagic infarction.

In a nutshell, the delay in elective surgeries caused by Covid-19 had a substantial impact on the market for neurovascular devices. The neurovascular devices sector is also harmed by cases of brain aneurysms that go undiagnosed and unreported. The usage of minimally invasive procedures and the support of R&D in this field are being driven by reduced postoperative discomfort and quicker recovery. Additionally, those who contracted the Covid-19 infection later exhibited neurological illness symptoms, which are most likely to foster market growth.

Direct Purchase of Neurovascular Devices Market Research Report at: https://www.delvens.com/checkout/neurovascular-devices-market-trends-forecast-till-2030

Key Findings

The cerebral angioplasty and stenting systems, cerebral embolization and aneurysm coiling devices, and support devices categories make up the neurovascular device market. Flow diversion devices, embolic coils, and liquid embolic agents are further divided into the category of cerebral embolization and aneurysm coiling devices. Embolic protection systems and carotid artery stents are further subcategories of cerebral angioplasty and stenting systems. Devices used in neuro thrombectomy are further divided into clot retrieval, suction, and vascular snare categories. Due to the rising incidence of acute ischemic stroke and the rising number of product launches by the major market players, the segment for neuro-thrombectomy devices is anticipated to develop at the greatest CAGR during the forecast period.

The therapeutic application segment is further segmented into the stroke, cerebral aneurysms, and others. Given the rising prevalence of stroke, hypertension, and other neurological illnesses in 2021, the stroke sector dominated the market with a CAGR of 6.2%. During the forecast period, the cerebral aneurysm segment is anticipated to increase at the highest CAGR primarily due to the rising incidence of intracranial aneurysms.

Delvens Industry Expert's Standpoint

The adoption of neurovascular devices among medical professionals and patients will continue to expand as a result of the rise in demand for minimally invasive surgical procedures and post-surgery techniques such as shorter hospital stays, affordability, and quicker patient recovery. The variety of neurovascular instruments available for treating various aneurysm types with higher safety and effectiveness will continue to grow thanks to novel technologies, and aneurysm management is always evolving with cutting-edge technology at the forefront of innovation.

Contact Us:

UNIT NO. 2126, TOWER B,
21ST FLOOR ALPHATHUM
SECTOR 90 NOIDA 201305, IN
+44-20-8638-5055
SALES@DELVENS.COM
WEBSITE: https://delvens.com/

About Us:

Delvens is a strategic advisory and consulting company headquartered in New Delhi, India. The company holds expertise in providing syndicated research reports, customized research reports and consulting services. Delvens qualitative and quantitative data is highly utilized by each level from niche to major markets, serving more than 1K prominent companies by assuring to provide the information on country, regional and global business environment. We have a database for more than 45 industries in more than 115+ major countries globally.

Delvens database assists the clients by providing in-depth information in crucial business decisions. Delvens offers significant facts and figures across various industries namely Healthcare, IT & Telecom, Chemicals & Materials, Semiconductor & Electronics, Energy, Pharmaceutical, Consumer Goods & Services, Food & Beverages. Our company provides an exhaustive and comprehensive understanding of the business environment.

This release was published on openPR.